Cost of Treatment of Affective Disorders

Wadsworth, W. V.; Tonge, W. L.; Barber, L. E. D.

doi:10.1016/s0140-6736(57)90837-1

Cited by 8 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another suggestion which emerges from several studies is that more intensive treatments and treatments with a higher weekly cost ultimately are associated with lower total costs of illness (Wadsworth et al 1957;Jones et al 1961;Jones & Sidebotham, 1962;Stern & Stern, 1963;McCaffree, 1966). The findings with the DGH(T) support this suggestion.…”

Section: Discussionmentioning

confidence: 90%

A comparison of two different services treating schizophrenia: a cost–benefit approach

1980

View full text Add to dashboard Cite

SYNOPSISThis study compares the clinical and social outcome for 2 cohorts of patients who had a first admission for schizophrenia 4 years earlier. One cohort was treated in a psychiatric unit attached to a teaching district general hospital (DGH(T)), while the other was treated at an area mental hospital (AMH) with modern rehabilitation facilities. The clinical outcome for the 2 cohorts was broadly similar, but the DGH(T) imposed less of a strain on relatives, and was associated with less unmet need. The DGH unit tended to have significantly shorter durations of stay for its patients, so that its total hospital costs were less than those for the AMH despite higher unit costs. The cost benefit analysis shows that, where these particular patients are concerned, the DGH(T) unit is economically superior to the AMH despite the fact that it supports a large teaching staff, and that these economic advantages are accompanied by various non-monetary advantages.

show abstract

Section: Discussionmentioning

confidence: 90%

A comparison of two different services treating schizophrenia: a cost–benefit approach

1980

View full text Add to dashboard Cite

show abstract

Cost implications of depression in older adults

Gottlieb

1988

Int J Geriat Psychiatry

View full text Add to dashboard Cite

The economic effects of mental disorder on individuals and their families and on society have received little scientific attention. Late life depression imposes substantial disability and it affects all spheres of function. Therefore, the development of rational health policy regarding this disorder requires prospective evaluation of related costs and the determination of the value of proposed interventions. A vigorous review and analysis of the existing literature provides a framework for synthesis of an aggressive research agenda which emphasizes four major areas: (1) Improved diagnostic rigour;(2) Integration of economic and epidemiologic methods; ( 3 ) Microscopic studies of individual and family costs; (4) Interventional benefit/ cost analysis.

show abstract

Cost–benefit analysis of a controlled trial of nurse therapy for neuroses in primary care

Ginsberg¹,

Marks²,

Waters³

1984

Psychol. Med.

View full text Add to dashboard Cite

SynopsisIn a randomized, controlled trial neurotic patients (mainly phobics and obsessive-compulsives) in primary care were assigned to behavioural psychotherapy from a nurse therapist or to routine care from their general practitioner. At the end of one year clinical outcome was significantly better in patients cared for by the nurse therapist. Economic outcome to one year, compared with the year before entering the trial, showed a slight decrease in the use of resources by the nurse therapist group (N = 22), and an increase in resource usage in the GP-treated group (N = 28), mainly due to the letter's increased absence from work and more hospital treatment and drugs. On the reasonable assumptions that nurse therapists treat 46 patients a year and that such patients treated behaviourally maintain their gains for 2 years, the economic benefits to society from nurse therapists treating such patients may outweigh the costs. This excludes any monetary value on the substantial clinical gains such as reduction in fear and anxiety. However, the numbers are small, few economic differences were significant, and many patients either did not complete the trial or waiting-list periods or they failed to return economic data. Conclusions must thus be tempered with caution, even though pre-treatment demographic and clinical data of non-returners were comparable with those of returners, and though the few drop-outs who could be rated at one year had not improved. The findings cannot be extrapolated to other types of clinical problem and treatment.

show abstract

Cost of Treatment of Affective Disorders

Cited by 8 publications

References 0 publications

A comparison of two different services treating schizophrenia: a cost–benefit approach

A comparison of two different services treating schizophrenia: a cost–benefit approach

Cost implications of depression in older adults

Cost–benefit analysis of a controlled trial of nurse therapy for neuroses in primary care

Contact Info

Product

Resources

About